Tacitus Therapeutics

About:

Tacitus Therapeutics is a clinical-stage biotechnology company that develops therapeutics for the treatment of blood cancers.

Website: https://tacitustherapeutics.com/

Description:

Tacitus Therapeutics is a clinical-stage biotechnology company dedicated to therapies using proprietary cell expansion, differentiation, and engineering platform technologies that overcome the limitations of traditional cell transplantation. The company was founded in 2019 and is headquartered in NYC.

Total Funding Amount:

$5M

Headquarters Location:

New York, New York, United States

Founded Date:

2019-01-01

Founders:

Camelia Iancu-Rubin, Ronald Hoffman

Number of Employees:

1-10

Last Funding Date:

2019-12-31

IPO Status:

Private

Industries:

© 2025 bioDAO.ai